Men taking dutasteride must wait at least 6 months after their last dose before donating blood. The FDA label states it directly: “Men being treated with AVODART should not donate blood until at least 6 months have passed following their last dose. The purpose of this deferred period is to prevent administration of dutasteride to a pregnant female transfusion recipient.” The American Red Cross lists the same wait: “Avodart or Jalyn (dutasteride) – wait 6 months from the last dose.” MedlinePlus gives the same figure. The length of the deferral tracks dutasteride’s terminal elimination half-life of approximately 5 weeks. Dutasteride is FDA-approved in the United States for bph/">benign prostatic hyperplasia only; use for hair loss is off-label, and the deferral applies either way.
Why Dutasteride Disqualifies You from Blood Donation
Blood donation rules protect the recipient as well as the donor. Dutasteride is contraindicated in pregnancy and in women of childbearing potential: it prevents the conversion of testosterone to DHT, a hormone the label describes as necessary for normal development of male genitalia, and in animal reproduction and developmental toxicity studies it inhibited normal development of the external genitalia in male fetuses. The label states the purpose of the donation deferral plainly, which is to prevent administration of dutasteride to a pregnant female transfusion recipient.
Because blood products from donors on teratogenic medications could potentially be transfused into women who are pregnant (often unknowingly), blood banks enforce deferral periods to prevent this risk.
Official Deferral Period
| Organization | Deferral Period After Last Dutasteride Dose |
|---|---|
| FDA (Avodart prescribing information, section 5.5) | 6 months from the last dose |
| American Red Cross (eligibility criteria) | 6 months from the last dose |
| MedlinePlus (National Library of Medicine) | Not while taking, and for 6 months after stopping |
| AABB (Association for the Advancement of Blood & Biotherapies) | Publishes the Donor History Questionnaires that blood centres use to screen donors; ask your centre which version it runs |
The deferral length is consistent with dutasteride’s pharmacokinetics. Its terminal elimination half-life is approximately 5 weeks at steady state, so five half-lives is about 25 weeks. The label states that, because of that long half-life, serum concentrations remain detectable, above 0.1 ng/mL, for up to 4 to 6 months after treatment is discontinued.
Dutasteride vs Finasteride: Blood Donation Rules
| Drug | Teratogen Classification | Blood Donation Deferral |
|---|---|---|
| Dutasteride (Avodart, Jalyn) | Contraindicated in pregnancy and in women of childbearing potential | 6 months after last dose |
| Finasteride (Propecia, Proscar) | Contraindicated in women who are or may become pregnant | 1 month after last dose |
Both deferral periods come from the same American Red Cross list, which gives 1 month for Proscar and Propecia (finasteride) and 6 months for Avodart and Jalyn (dutasteride). The gap follows the clearance rates: the Propecia label gives a mean terminal half-life of approximately 5 to 6 hours in men aged 18 to 60 and about 8 hours in men over 70, against approximately 5 weeks for dutasteride.
Platelet, Plasma, and Other Donation Types
The Red Cross publishes the 6-month wait under its general medication deferral list for blood donation. Its published criteria do not break the figure down by donation type, so the safe assumption is that it applies to whichever donation you are booking, and the donation centre is the authority on your specific case:
- Whole blood donation
- Platelet donation (apheresis)
- Plasma donation
- Red blood cell donation
- Bone marrow and stem cell donation: contact the National Marrow Donor Program (NMDP) directly. Its criteria are published separately from the blood-donation criteria above, so do not assume this deferral is the one that applies
Planning Around Donation
If you are a regular blood donor and are considering starting dutasteride, be aware that doing so will require a 6-month break from donation after any course of treatment. Some patients choose to make a pre-treatment donation before starting dutasteride, then plan their donation schedule around the required deferral period.
If you are unsure whether you are still within the 6-month window, contact the donation centre directly. They can advise based on your specific last-dose date. Do not donate if there is any uncertainty: preventing exposure of a pregnant transfusion recipient is the stated basis for the rule.
Sources
- FDA. Avodart (dutasteride) prescribing information, section 5.5 Blood Donation. accessdata.fda.gov
- American Red Cross. Eligibility Criteria: Alphabetical Listing (Medications). redcrossblood.org
- MedlinePlus. Dutasteride. medlineplus.gov
- AABB (Association for the Advancement of Blood & Biotherapies), publisher of the Donor History Questionnaires. aabb.org
- FDA. Propecia (finasteride) prescribing information, Clinical Pharmacology. accessdata.fda.gov